ArticleJournal for immunotherapy of cancer2026
Plasma cell-free RNA ITGB3 is associated with long-term clinical benefit in patients with non-small cell lung cancer receiving immunochemotherapy.
Yunbo Yu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.